Prostate cancer multiparametric magnetic resonance imaging visibility is a tumor-intrinsic phenomena

Abstract Multiparametric magnetic resonance imaging (mpMRI) is an emerging standard for diagnosing and prognosing prostate cancer, but ~ 20% of clinically significant tumors are invisible to mpMRI, as defined by the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) score of one or two...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Amanda Khoo, Lydia Y. Liu, Taylor Y. Sadun, Amirali Salmasi, Aydin Pooli, Ely Felker, Kathleen E. Houlahan, Vladimir Ignatchenko, Steven S. Raman, Anthony E. Sisk, Robert E. Reiter, Paul C. Boutros, Thomas Kislinger
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	BMC 2022-05-01
Σειρά:	Journal of Hematology & Oncology
Θέματα:	Proteomics Multiparametric magnetic resonance imaging Prostate cancer
Διαθέσιμο Online:	https://doi.org/10.1186/s13045-022-01268-6
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!